Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.11.2023 | Case report

Nivolumab

Thyroid dysfunction and lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Martins DC, et al. Transient Thyrotoxicosis with Immune Checkpoint Inhibitors Therapy: The Importance of Endocrine Evaluation. Journal of the Endocrine Society 4 (Suppl. 1): A569-A570 abstr. SAT-491, May 2020. Available from: URL: https://dx.doi.org/10.1210/jendso/bvaa046.1124 [abstract] Martins DC, et al. Transient Thyrotoxicosis with Immune Checkpoint Inhibitors Therapy: The Importance of Endocrine Evaluation. Journal of the Endocrine Society 4 (Suppl. 1): A569-A570 abstr. SAT-491, May 2020. Available from: URL: https://​dx.​doi.​org/​10.​1210/​jendso/​bvaa046.​1124 [abstract]
Metadaten
Titel
Nivolumab
Thyroid dysfunction and lack of efficacy
Publikationsdatum
01.11.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-50639-3

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Alendronic-acid

Case report

Antineoplastics

Case report

Multiple drugs

Case report

Lithium